e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Clinical application of paediatric lung function testing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reversibility of increased intrathoracic gas volume and decreased compliance in infants with pulmonary hyperperfusion and hypertension after repair of congenital heart disease
M. Henschen, J. M. Spolnik, M. Albiez, C. Schlensak, D. Kececioglu, S. Dittrich (Freiburg, Germany)
Source:
Annual Congress 2005 - Clinical application of paediatric lung function testing
Session:
Clinical application of paediatric lung function testing
Session type:
Poster Discussion
Number:
4283
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Henschen, J. M. Spolnik, M. Albiez, C. Schlensak, D. Kececioglu, S. Dittrich (Freiburg, Germany). Reversibility of increased intrathoracic gas volume and decreased compliance in infants with pulmonary hyperperfusion and hypertension after repair of congenital heart disease. Eur Respir J 2005; 26: Suppl. 49, 4283
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
Related content which might interest you:
Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
Source: Eur Respir Rev 2009; 18: 154-161
Year: 2009
Changing demographics of pulmonary arterial hypertension in congenital heart disease
Source: Eur Respir Rev 2010 19: 308-313
Year: 2010
Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension
Source: Eur Respir J 2015; 46: 422-430
Year: 2015
Usefulness of differential blood gas exchange assessment in patients with severe pulmonary arterial hypertension (PAH) associated to congenital heart disease (CHD)
Source: Eur Respir J 2005; 26: Suppl. 49, 351s
Year: 2005
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012
Effect of sitaxentan in patients with pulmonary arterial hypertension associated to congenital heart diseases
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Double combination therapy in patients with pulmonary arterial hypertension associated with congenital heart defects
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Spontaneous haemodynamic variability during right heart catetherisation in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
Characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease in the French PAH registry
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Hemodynamic assessment of pulmonary hypertension in grown-up congenital heart disease
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011
Pulmonary hypertension by right heart catheterization in patients with interstitial lung diease
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Pulmonary vascular distensibility in pulmonary hypertension due to left heart disease
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
Pulmonary hypertension in left heart, respiratory and trombo-embolic pulmonary disease
Source: International Congress 2015 – Pulmonary hypertension
Year: 2015
Intracardiac shunt measurement by MRI in patients with pulmonary arterial hypertension caused by a congenital septum defect
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005
Nebulised Iloprost for pulmonary arterial hypertension associated with congenital heart disease: one centre's experience
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001
The association between resting and mild-to-moderate exercise pulmonary artery pressure
Source: Eur Respir J 2012; 39: 313-318
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept